Transthyretin stabilizer therapy increases naturally-occurring antibodies in ATTR cardiomyopathy.
Saved in:
| Title: | Transthyretin stabilizer therapy increases naturally-occurring antibodies in ATTR cardiomyopathy. |
|---|---|
| Authors: | Settelmeier, Stephan1,2 (AUTHOR), Agranovski, Daniel3 (AUTHOR), Steinhardt, Maximilian4,5 (AUTHOR), Waydhas, Sarah1,2 (AUTHOR), Gering, Ian6 (AUTHOR), Cejka, Vladimir4 (AUTHOR), Morbach, Caroline4,7,8 (AUTHOR), Störk, Stefan4,7 (AUTHOR), Willbold, Dieter6,9 (AUTHOR), Küppers, Ralf10 (AUTHOR), Vogel, Julia1,2 (AUTHOR), Michel, Lars1,2 (AUTHOR), Carpinteiro, Alexander2,11 (AUTHOR), Reinhardt, H. Christian2,11 (AUTHOR), Dodel, Richard3 (AUTHOR), Rassaf, Tienush1,2 (AUTHOR), Ross, Alexander J.3 (AUTHOR), Hendgen-Cotta, Ulrike B.1,2 (AUTHOR) ulrike.hendgen-cotta@uk-essen.de |
| Source: | Amyloid. Apr2026, p1-17. 17p. 4 Illustrations. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
